Cargando…
Is there value in coronavirus disease 2019 vaccine and vaccine excipient skin testing or split dosing?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712058/ https://www.ncbi.nlm.nih.gov/pubmed/36464396 http://dx.doi.org/10.1016/j.anai.2022.09.001 |
| _version_ | 1784841715078660096 |
|---|---|
| author | Greenhawt, Matthew |
| author_facet | Greenhawt, Matthew |
| author_sort | Greenhawt, Matthew |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9712058 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97120582022-12-01 Is there value in coronavirus disease 2019 vaccine and vaccine excipient skin testing or split dosing? Greenhawt, Matthew Ann Allergy Asthma Immunol Editorial American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2022-12 2022-12-01 /pmc/articles/PMC9712058/ /pubmed/36464396 http://dx.doi.org/10.1016/j.anai.2022.09.001 Text en © 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Editorial Greenhawt, Matthew Is there value in coronavirus disease 2019 vaccine and vaccine excipient skin testing or split dosing? |
| title | Is there value in coronavirus disease 2019 vaccine and vaccine excipient skin testing or split dosing? |
| title_full | Is there value in coronavirus disease 2019 vaccine and vaccine excipient skin testing or split dosing? |
| title_fullStr | Is there value in coronavirus disease 2019 vaccine and vaccine excipient skin testing or split dosing? |
| title_full_unstemmed | Is there value in coronavirus disease 2019 vaccine and vaccine excipient skin testing or split dosing? |
| title_short | Is there value in coronavirus disease 2019 vaccine and vaccine excipient skin testing or split dosing? |
| title_sort | is there value in coronavirus disease 2019 vaccine and vaccine excipient skin testing or split dosing? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712058/ https://www.ncbi.nlm.nih.gov/pubmed/36464396 http://dx.doi.org/10.1016/j.anai.2022.09.001 |
| work_keys_str_mv | AT greenhawtmatthew istherevalueincoronavirusdisease2019vaccineandvaccineexcipientskintestingorsplitdosing |